| |
|
|
|
|
|
|
|||
|
Blood, 1 February 2006, Vol. 107, No. 3, pp. 940-946. Prepublished online as a Blood First Edition Paper on October 4, 2005; DOI 10.1182/blood-2004-11-4403.
Submitted December 2, 2004
Neuro-Oncology Branch, National Cancer Institute, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA * Corresponding author; email: hfine{at}mail.nih.gov.
Subpopulations of bone marrow-derived cells can be induced to assume a number of endothelial properties in vitro. However, their ability to form a functional vascular barrier has not been demonstrated. We report that human CD14+ peripheral blood monocytes cultured under angiogenic conditions develop a number of phenotypic and functional properties similar to brain microvascular endothelial cells. These cells express the tight junction proteins zonula occludens 1 (ZO-1) and occludin and form a barrier with a trans-cellular electrical resistance (TCER) greater than 100 ohm cm2 and low permeability to 4 kD and 20 kD dextrans. The TCER of the cellular barrier is decreased by bradykinin and histamine. We also demonstrate that these cells are associated with repairing vasculature in areas of brain and skin injury. Our data suggest that CD14+ peripheral blood monocytes participate in the repair of the vascular barrier after brain injury.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2005 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||